- £18.86m
- £17.75m
- £6.53m
Retail Offer
Placings and Subscription
Brief: IXICO Announces About 1.5 Mln Stg Contract Extension
Brief: IXICO FY Gross Margin 49%
Financial Results for year ended 30 September 2025
Operational Update
Notice of 2025 Full Year Results and IMC
Brief: IXICO Announces Phase 3 Clinical Trial Contract Win Worth Over 3.5 Mln Stg Over Four Years
Clinical Trial Contract Win
Trading Update
Brief: Ixico PLC Announces New Contract And Extension Worth Total Of £1.2 Million
New contract win and contract extension
Brief: IXICO Signs £1.3 Million Neuroimaging Contracts
Contract Win
Brief: IXICO Partners With Global Alzheimer's Platform Foundation
Strategic Data Partnership with GAP
Brief: Ixico Expects Revenue Growth Will Continue Into 2026
Trading Update
Share option awards and PDMR Dealing